vs
agilon health, inc.（AGL）与Williams-Sonoma, Inc.（WSM）财务数据对比。点击上方公司名可切换其他公司
Williams-Sonoma, Inc.的季度营收约是agilon health, inc.的1.2倍（$1.9B vs $1.6B），Williams-Sonoma, Inc.净利率更高（12.8% vs -12.0%，领先24.9%），Williams-Sonoma, Inc.同比增速更快（4.6% vs 3.1%），Williams-Sonoma, Inc.自由现金流更多（$248.1M vs $-23.5M），过去两年agilon health, inc.的营收复合增速更高（-1.1% vs -9.1%）
agilon health是一家美国医疗保健企业，主要与基层医疗服务提供者合作，为联邦医疗保险覆盖的老年群体提供价值导向型医疗解决方案，为医生提供行政支持、临床工具及风险管理框架，在提升诊疗效果的同时降低医疗成本，业务覆盖美国20余个州。
Williams-Sonoma, Inc.是美国知名家居零售企业，1956年由查尔斯·E·威廉姆斯创立，主营高品质炊具、家居家电、家居软装等多元品类产品，在家居消费领域拥有广泛的用户基础与较高的市场认可度。
AGL vs WSM — 直观对比
营收规模更大
WSM
是对方的1.2倍
$1.6B
营收增速更快
WSM
高出1.5%
3.1%
净利率更高
WSM
高出24.9%
-12.0%
自由现金流更多
WSM
多$271.6M
$-23.5M
两年增速更快
AGL
近两年复合增速
-9.1%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.6B | $1.9B |
| 净利润 | $-188.9M | $241.6M |
| 毛利率 | — | 46.1% |
| 营业利润率 | -12.3% | 17.0% |
| 净利率 | -12.0% | 12.8% |
| 营收同比 | 3.1% | 4.6% |
| 净利润同比 | -78.5% | -3.0% |
| 每股收益（稀释后） | — | $1.96 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AGLWSM
| Q4 25 | $1.6B | $1.9B | ||
| Q3 25 | $1.4B | $1.8B | ||
| Q2 25 | $1.4B | $1.7B | ||
| Q1 25 | $1.5B | $2.5B | ||
| Q4 24 | $1.5B | $1.8B | ||
| Q3 24 | $1.5B | $1.8B | ||
| Q2 24 | $1.5B | $1.7B | ||
| Q1 24 | $1.6B | $2.3B |
净利润AGLWSM
| Q4 25 | $-188.9M | $241.6M | ||
| Q3 25 | $-110.2M | $247.6M | ||
| Q2 25 | $-104.4M | $231.3M | ||
| Q1 25 | $12.1M | $384.9M | ||
| Q4 24 | $-105.8M | $249.0M | ||
| Q3 24 | $-117.6M | $225.7M | ||
| Q2 24 | $-30.7M | $265.7M | ||
| Q1 24 | $-6.1M | $354.4M |
毛利率AGLWSM
| Q4 25 | — | 46.1% | ||
| Q3 25 | — | 47.1% | ||
| Q2 25 | — | 44.3% | ||
| Q1 25 | — | 45.2% | ||
| Q4 24 | — | 46.7% | ||
| Q3 24 | — | 46.2% | ||
| Q2 24 | — | 48.3% | ||
| Q1 24 | — | 46.0% |
营业利润率AGLWSM
| Q4 25 | -12.3% | 17.0% | ||
| Q3 25 | -9.1% | 17.9% | ||
| Q2 25 | -8.3% | 16.8% | ||
| Q1 25 | -1.4% | 20.1% | ||
| Q4 24 | -7.1% | 17.8% | ||
| Q3 24 | -9.2% | 16.2% | ||
| Q2 24 | -2.9% | 19.5% | ||
| Q1 24 | -0.4% | 20.1% |
净利率AGLWSM
| Q4 25 | -12.0% | 12.8% | ||
| Q3 25 | -7.7% | 13.5% | ||
| Q2 25 | -7.5% | 13.4% | ||
| Q1 25 | 0.8% | 15.6% | ||
| Q4 24 | -6.9% | 13.8% | ||
| Q3 24 | -8.1% | 12.6% | ||
| Q2 24 | -2.1% | 16.0% | ||
| Q1 24 | -0.4% | 15.6% |
每股收益（稀释后）AGLWSM
| Q4 25 | — | $1.96 | ||
| Q3 25 | — | $2.00 | ||
| Q2 25 | — | $1.85 | ||
| Q1 25 | — | $1.02 | ||
| Q4 24 | — | $1.96 | ||
| Q3 24 | — | $1.74 | ||
| Q2 24 | — | $4.07 | ||
| Q1 24 | — | $5.42 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $173.7M | $884.7M |
| 总债务越低越好 | $35.0M | — |
| 股东权益账面价值 | $126.7M | $2.1B |
| 总资产 | $1.3B | $5.3B |
| 负债/权益比越低杠杆越低 | 0.28× | — |
8季度趋势，按日历期对齐
现金及短期投资AGLWSM
| Q4 25 | $173.7M | $884.7M | ||
| Q3 25 | $171.7M | $985.8M | ||
| Q2 25 | $171.4M | $1.0B | ||
| Q1 25 | $136.9M | $1.2B | ||
| Q4 24 | $188.2M | $826.8M | ||
| Q3 24 | $148.2M | $1.3B | ||
| Q2 24 | $109.5M | $1.3B | ||
| Q1 24 | $111.7M | $1.3B |
总债务AGLWSM
| Q4 25 | $35.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益AGLWSM
| Q4 25 | $126.7M | $2.1B | ||
| Q3 25 | $306.1M | $2.1B | ||
| Q2 25 | $408.9M | $2.2B | ||
| Q1 25 | $500.3M | $2.1B | ||
| Q4 24 | $471.0M | $1.9B | ||
| Q3 24 | $574.9M | $2.3B | ||
| Q2 24 | $676.6M | $2.2B | ||
| Q1 24 | $689.3M | $2.1B |
总资产AGLWSM
| Q4 25 | $1.3B | $5.3B | ||
| Q3 25 | $1.6B | $5.2B | ||
| Q2 25 | $1.7B | $5.2B | ||
| Q1 25 | $1.9B | $5.3B | ||
| Q4 24 | $1.7B | $5.0B | ||
| Q3 24 | $2.1B | $5.2B | ||
| Q2 24 | $2.2B | $5.2B | ||
| Q1 24 | $2.3B | $5.3B |
负债/权益比AGLWSM
| Q4 25 | 0.28× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-20.5M | $316.3M |
| 自由现金流经营现金流 - 资本支出 | $-23.5M | $248.1M |
| 自由现金流率自由现金流/营收 | -1.5% | 13.2% |
| 资本支出强度资本支出/营收 | 0.2% | 3.6% |
| 现金转化率经营现金流/净利润 | — | 1.31× |
| 过去12个月自由现金流最近4个季度 | $-119.0M | $1.1B |
8季度趋势，按日历期对齐
经营现金流AGLWSM
| Q4 25 | $-20.5M | $316.3M | ||
| Q3 25 | $-18.2M | $282.7M | ||
| Q2 25 | $-35.1M | $118.9M | ||
| Q1 25 | $-32.0M | $633.5M | ||
| Q4 24 | $16.4M | $253.5M | ||
| Q3 24 | $-7.7M | $246.5M | ||
| Q2 24 | $-18.7M | $226.8M | ||
| Q1 24 | $-47.8M | $674.9M |
自由现金流AGLWSM
| Q4 25 | $-23.5M | $248.1M | ||
| Q3 25 | $-21.3M | $230.7M | ||
| Q2 25 | $-38.3M | $60.7M | ||
| Q1 25 | $-35.8M | $566.3M | ||
| Q4 24 | $13.2M | $170.1M | ||
| Q3 24 | $-11.2M | $215.1M | ||
| Q2 24 | $-22.0M | $187.3M | ||
| Q1 24 | $-50.9M | $621.2M |
自由现金流率AGLWSM
| Q4 25 | -1.5% | 13.2% | ||
| Q3 25 | -1.5% | 12.6% | ||
| Q2 25 | -2.7% | 3.5% | ||
| Q1 25 | -2.3% | 23.0% | ||
| Q4 24 | 0.9% | 9.4% | ||
| Q3 24 | -0.8% | 12.0% | ||
| Q2 24 | -1.5% | 11.3% | ||
| Q1 24 | -3.2% | 27.3% |
资本支出强度AGLWSM
| Q4 25 | 0.2% | 3.6% | ||
| Q3 25 | 0.2% | 2.8% | ||
| Q2 25 | 0.2% | 3.4% | ||
| Q1 25 | 0.3% | 2.7% | ||
| Q4 24 | 0.2% | 4.6% | ||
| Q3 24 | 0.2% | 1.8% | ||
| Q2 24 | 0.2% | 2.4% | ||
| Q1 24 | 0.2% | 2.4% |
现金转化率AGLWSM
| Q4 25 | — | 1.31× | ||
| Q3 25 | — | 1.14× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | -2.64× | 1.65× | ||
| Q4 24 | — | 1.02× | ||
| Q3 24 | — | 1.09× | ||
| Q2 24 | — | 0.85× | ||
| Q1 24 | — | 1.90× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AGL
| Medical Services | $1.6B | 100% |
| Other Operating | $2.5M | 0% |
WSM
暂无分部数据
